Franklin Resources Portfolio holdings
Franklin Resources, Inc., commonly known as Franklin Templeton, was founded in 1947 by Rupert H. Johnson, Sr., and is headquartered in San Mateo, California, operating as a global investment management firm managing hundreds of billions in assets. The company offers a wide range of investment products, including mutual funds, ETFs, fixed-income portfolios, and alternative investments, serving individual investors, financial advisors, and institutions across over 150 countries. Known for its acquisition-driven growth—such as the 1992 purchase of Templeton Investments and the 2020 addition of Legg Mason—Franklin Templeton combines diverse strategies under a single brand, emphasizing both active management and income-focused solutions like its flagship Franklin Income Fund. With a reputation for adaptability and a client-centric approach, it remains a major player in the global asset management industry.
Top Buys
| 1 |
AVGOP
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
|
$707M |
| 2 |
Oracle
ORCL
|
$516M |
| 3 |
Franklin US Core Bond ETF
FLCB
|
$361M |
| 4 |
Franklin Investment Grade Corporate ETF
FLCO
|
$336M |
| 5 |
Cisco
CSCO
|
$248M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$615M |
| 2 |
Wells Fargo
WFC
|
$544M |
| 3 |
JPMorgan Chase
JPM
|
$409M |
| 4 |
Bristol-Myers Squibb
BMY
|
$374M |
| 5 |
Capital One
COF
|
$354M |
Sector Composition
| 1 | Technology | 16.94% |
| 2 | Healthcare | 15.83% |
| 3 | Financials | 13.53% |
| 4 | Industrials | 9.19% |
| 5 | Consumer Discretionary | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Berkshire Hathaway Class B
BRK.B
$1.08T
| $276M | 0.14% |
1,217,510
+788,528
| +184% | +$179M |
|
|
NAV
177
DELISTED
Navistar International
NAV
| $275M | 0.14% |
9,486,960
-222,537
| -2% | -$6.44M |
|
178
Labcorp
LH
$22.6B
| $273M | 0.14% |
1,612,797
+17,010
| +1% | +$2.88M |
|
179
Monster Beverage
MNST
$61.6B
| $272M | 0.14% |
4,286,169
-13,232
| -0.3% | -$841K |
|
180
Truist Financial
TFC
$59.5B
| $271M | 0.14% |
4,807,784
+17,858
| +0.4% | +$1.01M |
|
181
AstraZeneca
AZN
$254B
| $270M | 0.14% |
5,417,840
+30,382
| +0.6% | +$1.51M |
|
182
First Horizon
FHN
$11.3B
| $270M | 0.14% |
16,274,927
+268,700
| +2% | +$4.45M |
|
183
Microchip Technology
MCHP
$33.9B
| $268M | 0.14% |
2,559,804
-368,960
| -13% | -$38.6M |
|
184
Idexx Laboratories
IDXX
$50.2B
| $267M | 0.14% |
1,022,903
+7,546
| +0.7% | +$1.97M |
|
185
Constellation Brands
STZ
$26.1B
| $267M | 0.14% |
1,407,672
-7,411
| -0.5% | -$1.41M |
|
186
Fortive
FTV
$15.9B
| $266M | 0.14% |
3,477,014
-78,096
| -2% | -$5.97M |
|
187
PTC Therapeutics
PTCT
$4.38B
| $263M | 0.14% |
5,470,308
+41,659
| +0.8% | +$2M |
|
188
DTE Energy
DTE
$28.1B
| $262M | 0.14% |
2,015,724
+307,765
| +18% | +$40M |
|
189
Entergy
ETR
$38.8B
| $256M | 0.13% |
2,139,609
+619
| +0% | +$74.2K |
|
190
ASML
ASML
$289B
| $256M | 0.13% |
865,118
-262
| -0% | -$77.5K |
|
|
RETA
191
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $254M | 0.13% |
1,243,131
-11,896
| -0.9% | -$2.43M |
|
192
Pentair
PNR
$17.5B
| $253M | 0.13% |
5,522,646
-55,416
| -1% | -$2.54M |
|
193
LivaNova
LIVN
$3.05B
| $253M | 0.13% |
3,348,444
+97,159
| +3% | +$7.33M |
|
194
EOG Resources
EOG
$66.3B
| $252M | 0.13% |
3,013,788
-7,606
| -0.3% | -$637K |
|
195
Vertex Pharmaceuticals
VRTX
$102B
| $251M | 0.13% |
1,146,989
-100,879
| -8% | -$22.1M |
|
196
Regeneron Pharmaceuticals
REGN
$61B
| $248M | 0.13% |
659,181
-42,834
| -6% | -$16.1M |
|
197
iShares Core MSCI EAFE ETF
IEFA
$148B
| $246M | 0.13% |
3,777,025
+304
| +0% | +$19.8K |
|
198
AB InBev
BUD
$116B
| $244M | 0.13% |
2,979,062
+2,023
| +0.1% | +$166K |
|
|
GWPH
199
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $240M | 0.13% |
2,293,031
+467,520
| +26% | +$48.9M |
|
200
Tyler Technologies
TYL
$23.9B
| $239M | 0.13% |
797,481
-18,058
| -2% | -$5.42M |
|